Dr. McCurdy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-615-0063- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Pennsylvania Health SystemResidency, Internal Medicine, 2009 - 2012
Georgetown University School of MedicineClass of 2009
Certifications & Licensure
PA State Medical License 2009 - 2024
MD State Medical License 2012 - 2019- American Board of Internal MedicineOncology
Awards, Honors, & Recognition
- Most Cited Articles for Grade 2 Acute GVHD and Higher Nucleated Dose Improves PFS after HLA-Haploidentical BMT with PTCy Biology of Blood and Marrow Transplantation, 2019
- Conquer Cancer Young Investigator Award American Society of Clinical Oncology, 2015
- American Society of Hematology, Abstract Achievement Award American Society of Hematology, 2014
- Join now to see all
Clinical Trials
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies Start of enrollment: 2018 Sep 21
- APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS) Start of enrollment: 2019 Jan 11
- Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) Start of enrollment: 2019 Jun 14
- Join now to see all
Publications & Presentations
PubMed
- Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine E Lai, Alison W Loren, Selina M Luger, Andrew H Ma...> ;Haematologica. 2024 Apr 18
- Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain.Pashna N Munshi, Shannon R McCurdy> ;American Journal of Hematology. 2024 May 1
- Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.Anthony D Sung, Thuy Koll, Shannon H Gier, Alessandro Racioppi, Griffin White, Meagan Lew, Marcia Free, Priyal Agarwal, Lauren M Bohannon, Ernaya J Johnson, Bharathi S...> ;Transplantation and Cellular Therapy. 2024 Apr 1
- Join now to see all
Abstracts/Posters
- Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant AbstractShannon R. McCurdy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Penn Medicine at the 2023 ASH MeetingDecember 7th, 2023
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
